Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform

Creative Commons License

Nasrollahpour H., IŞILDAK İ., Rashidi M., Hashemi E. A., Naseri A., Khalilzadeh B.

CANCER NANOTECHNOLOGY, cilt.12, sa.1, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1186/s12645-021-00082-y
  • Dergi Adı: CANCER NANOTECHNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: HER-2, ECL, Bioassay, Breast cancer, Biomedical analysis, Ruthenium, Protein, Biocompatible polymer, Chitosan, Biotechnology, [Ru(bpy)(3)](2+)
  • Yıldız Teknik Üniversitesi Adresli: Evet

Özet

Background: In this label-free bioassay, an electrochemiluminescence (ECL) immunosensor was developed for the quantification of breast cancer using HER-2 protein as a metastatic biomarker.